Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

Heikenwalder, Mathias, Polymenidou, Magdalini, Junt, Tobias, Sigurdson, Christina, Wagner, Hermann, Akira, Shizuo, Zinkernagel, Rolf, Aguzzi, Adriano·2004·Nature Medicine

DOI 10.1038/nm987

Cited by (444)

Items 101–200 of 444

Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy
Darya Alizadeh, Leying Zhang, Christine E. Brown, Omar Farrukh, Michael C. Jensen, Behnam Badie · 2010 · Clinical Cancer Research
Antiprion immunotherapy: to suppress or to stimulate?
Adriano Aguzzi, Christina J. Sigurdson · 2004 · Nature reviews. Immunology
High IFN- α Responses Associated with Depletion of Lymphocytes and Natural IFN-Producing Cells During Classical Swine Fever
Artur Summerfield, Marco P. Alves, Nicolas Ruggli, M.G.M. de Bruin, Kenneth C. McCullough · 2006 · Journal of Interferon & Cytokine Research
Microenvironment of Tumor-Draining Lymph Nodes: Opportunities for Liposome-Based Targeted Therapy
Siddarth Chandrasekaran, Michael R. King · 2014 · International Journal of Molecular Sciences
Toward Therapy of Human Prion Diseases
Adriano Aguzzi, Asvin KK Lakkaraju, Karl Frontzek · 2017 · The Annual Review of Pharmacology and Toxicology
Immune Mechanisms and Therapeutic Potential of CpG Oligodeoxynucleotides
Heather L. Wilson, Arshud M. Dar, Scott Napper, A. Marianela Lopez, Lorne A. Babiuk, George Mutwiri · 2006 · International Reviews of Immunology
Progress and problems in the biology, diagnostics, and therapeutics of prion diseases
Adriano Aguzzi, Mathias F Heikenwälder, Gino Miele · 2004 · Journal of Clinical Investigation
TNF-α Contributes to Lymphoid Tissue Disorganization and Germinal Center B Cell Suppression during Intracellular Bacterial Infection
Popescu, Maria, Cabrera-Martinez, Berenice, Winslow, Gary M · 2019 · The Journal of Immunology
DNA Nanostructure‐Based Systems for Intelligent Delivery of Therapeutic Oligonucleotides
Qinqin Hu, Sheng Wang, Lihua Wang, Hongzhou Gu, Chunhai Fan · 2018 · Advanced Healthcare Materials
Amphiphilic Polyanhydride Nanoparticles Stabilize Bacillus anthracis Protective Antigen
Latrisha K. Petersen, Yashdeep Phanse, Amanda E. Ramer‐Tait, Michael J. Wannemuehler, Balaji Narasimhan · 2012 · Molecular Pharmaceutics
Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration
Barbara R. von Beust, Pål Johansen, Kent A. Smith, Adrian I Bot, Tazio Storni, Thomas M. Kündig · 2005 · European Journal of Immunology
Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy
Yuki Hori, Patrick Stern, Richard O. Hynes, Darrell J. Irvine · 2009 · Biomaterials
Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity
Naoya Kojima, Le Biao, Tomoko Nakayama, Mariko Ishii, Yuzuru Ikehara, Kunio Tsujimura · 2008 · Journal of Controlled Release
B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: Modulation by BCR and CD40, and relevance to T-independent antibody responses
Egest James Pone, Zheng Lou, Tonika Lam, Milton L. Greenberg, Rui Wang, Zhenming Xu, Paolo Casali · 2014 · Autoimmunity
Excessive Tryptophan Catabolism Along the Kynurenine Pathway Precedes Ongoing Sepsis in Critically Ill Patients
Jan-Philip Zeden, Gerhard Fusch, Birte Holtfreter, Joerg C. Schefold, P. Reinke, Grażyna Domańska, Johannes‐Peter Haas, Matthias Gruendling, Alexandra Westerholt, Christine Schuett · 2010 · Anaesthesia and Intensive Care
Immunostimulatory DNA as a vaccine adjuvant
Debbie Higgins, Jason D. Marshall, Paula Traquina, Gary Van Nest, Brian D. Livingston · 2007 · Expert Review of Vaccines
Quantification of Poly(I:C)-Mediated Protection against Genital Herpes Simplex Virus Type 2 Infection
Melissa M. Herbst‐Kralovetz, Richard B. Pyles · 2006 · Journal of Virology
A Toll for lupus
Hans‐Joachim Anders · 2005 · Lupus
In vivo Colocalization of Antigen and CpG within Dendritic Cells Is Associated with the Efficacy of Cancer Immunotherapy
Stefan Nierkens, Martijn H. den Brok, Roger P.M. Sutmuller, Oliver Martin Grauer, Erik J. Bennink, Mary E. Morgan, Carl Gustav Figdor, Theo J. M. Ruers, Gosse J. Adema · 2008 · Cancer Research
Inhibition of Autoimmune Diabetes by TLR2 Tolerance
Do‐Hoon Kim, June-Chul Lee, Sunshin Kim, Seung Hoon Oh, Moon‐Kyu Lee, Kwang‐Won Kim, Myung-Shik Lee · 2011 · The Journal of Immunology
Adjuvants for malaria vaccines
Rhea N. Coler, Darrick Carter, Martin Friede, Steven G. Reed · 2009 · Parasite Immunology
Modified Fe3O4 Magnetic Nanoparticle Delivery of CpG Inhibits Tumor Growth and Spontaneous Pulmonary Metastases to Enhance Immunotherapy
Xueyan Zhang, Fengbo Wu, Ke Men, Rong Huang, Bailin Zhou, Rui Zhang, Rui Zou, Li Yang · 2018 · Nanoscale Research Letters
Toll‐like receptor 9‐mediated induction of the immunosuppressive pathway of tryptophan catabolism
Francesca Fallarino, Paolo Puccetti · 2005 · European Journal of Immunology
Viral 5′‐triphosphate RNA and non‐CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR‐independent immune responses
Ramanjaneyulu Allam, Rahul D. Pawar, Onkar P. Kulkarni, Veit Hornung, Günter Hartmann, Stephan Segerer, Shizuo Akira, Stefan Endres, Hans‐Joachim Anders · 2008 · European Journal of Immunology
Toll-like Receptor-7 Tolerizes Malignant B Cells and Enhances Killing by Cytotoxic Agents
Yonghong Shi, Dionne White, Liwei He, Richard Lloyd Miller, David Spaner · 2007 · Cancer Research
Efficient Delivery of the Toll-like Receptor Agonists Polyinosinic:Polycytidylic Acid and CpG to Macrophages by Acetalated Dextran Microparticles
Kevin J. Peine, Eric M. Bachelder, Zachary VanGundy, Tracy L. Papenfuss, Deanna J. Brackman, Mathew D. Gallovic, Kevin L. Schully, John T. Pesce, Andrea Keane‐Myers, Kristy M. Ainslie · 2013 · Molecular Pharmaceutics
HIV-1 immunopathogenesis in humanized mouse models
Liguo Zhang, Lishan Su · 2012 · Cellular and Molecular Immunology
Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9
Jörg Vollmer · 2005 · Expert Opinion on Biological Therapy
Increasing the efficacy of tumor cell vaccines by enhancing cross priming
Brian M. Andersen, John R. Ohlfest · 2012 · Cancer Letters
Anthrax, toxins and vaccines: a 125-year journey targetingBacillus anthracis
Jean‐Nicolas Tournier, Robert G. Ulrich, Anne Quesnel‐Hellmann, Mansour Mohamadzadeh, Bradley G. Stiles · 2009 · Expert Review of Anti-infective Therapy
Innate Immune Defenses Induced by CpG Do Not Promote Vaccine-Induced Protection against Foot-and-Mouth Disease Virus in Pigs
Marco P. Alves, Laurence Guzylack‐Piriou, Veronique Juillard, Jean-Christophe Audonnet, T.R. Doel, Harry Dale Dawson, William T. Golde, Heidi Gerber, Nadja Peduto, Kenneth C. McCullough et al. · 2009 · Clinical and Vaccine Immunology
Vaccinations with T‐helper type 1 directing adjuvants have different suppressive effects on the development of allergen‐induced T‐helper type 2 responses
Claudia Milena Trujillo-Vargas, Katrin D Mayer, Thomas Bickert, Alois Palmetshofer, S. Grunewald, José R. Ramírez‐Pineda, Tobias Polte, Gesine Hansen, Gisela Wohlleben, Klaus Joseph Erb · 2005 · Clinical & Experimental Allergy
Role of endogenous retroviruses in murine SLE
Baudino, Lucie, Yoshinobu, Kumiko, Morito, Naoki, Santiago-Raber, Marie-Laure, Izui, Shozo · 2010 · Autoimmunity Reviews
Toxicity of Cationic Lipid‐DNA Complexes
Nelson S. Yew, Ronald K. Scheule · 2005 · Advances in genetics
Molecular mechanisms of autoimmunity triggered by microbial infection.
Hans‐Joachim Anders, Daniel Zecher, Rahul D. Pawar, Prashant S. Patole · 2005 · Arthritis Research & Therapy
Stimulation via Toll‐like receptor 9 reduces Cryptococcus neoformans‐induced pulmonary inflammation in an IL‐12‐dependent manner
Lorna Edwards, Andrew Evan Williams, Arthur Μ. Krieg, Aaron J. Rae, Robert J. Snelgrove, Tracy Hussell · 2004 · European Journal of Immunology
Polylactide-Coglycolide Microspheres CoEncapsulating Recombinant Tandem Prion Protein with CpG-Oligonucleotide Break Self-Tolerance to Prion Protein in Wild-Type Mice and Induce CD4 and CD8 T Cell Responses
Gunnar Kaiser-Schulz, Antje Heit, Leticia Quintanilla‐Martínez, Franziska Hammerschmidt, Simone Hess, Luise Jennen, Human Rezaei, Hermann Wagner, Hermann M. Schätzl · 2007 · The Journal of Immunology
Nanomaterials-Involved Tumor-Associated Macrophages’ Reprogramming for Antitumor Therapy
Shulan Li, Hua‐Ying Hou, Xu Chu, Yuying Zhu, Yujuan Zhang, Meng‐Die Duan, Junyi Liu, Yi Liu · 2024 · ACS Nano
Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis
Vahid Heravi Shargh, Mahmoud Reza Jaafari, Ali Khamesipour, Iman Jaafari, Seyed Amir Jalali, Azam Abbasi, Ali Badiee · 2012 · Vaccine
Scientific and Regulatory Policy Committee Points-to-consider Paper*
Jeffery A. Engelhardt, Pierluigi Fant, Silvia Guionaud, Scott P. Henry, Michael W. Leach, Calvert S. Louden, Marshall S. Scicchitano, James L. Weaver, Tanja S. Zabka, Kendall S. Frazier · 2015 · Toxicologic Pathology
CpG oligodeoxynucleotides as mucosal adjuvants
Sumiko Iho, Jun‐ichi Maeyama, Fumiko Suzuki · 2015 · Human Vaccines & Immunotherapeutics
Innate pro–B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells
Ruddy Montandon, Sarantis Korniotis, Esther Layseca‐Espinosa, Christophe Gras, Jérôme Megret, Sophie Ezine, Michel Dy, Flora Zavala · 2013 · Proceedings of the National Academy of Sciences
A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury
Brian T. David, Ayomi Ratnayake, Matthew A. Amarante, Naresh Parvath Reddy, Wei Dong, Sujitha Sampath, Robert F. Heary, Stella Elkabes · 2013 · Neurobiology of Disease
Various ways to improve whole cancer cell vaccines
Laetitia Cicchelero, H. de Rooster, Niek N. Sanders · 2014 · Expert Review of Vaccines
Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists
Marij J.P. Welters, Martijn S. Bijker, Susan J. F. van den Eeden, Kees L. M. C. Franken, Cornelis J.M. Melief, Rienk Offringa, Sjoerd H. van der Burg · 2006 · Vaccine
CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils.
Spinner, Daryl S, Kascsak, Regina B, LaFauci, Giuseppe, Meeker, Harry C, Ye, Xuemin, Flory, Michael J, Kim, Jae Il, Schuller-Levis, Georgia B, Levis, William R, Wisniewski, Thomas et al. · 2007 · Journal of Leukocyte Biology
Immune Responses Against Classical Swine Fever Virus: Between Ignorance and Lunacy
Artur Summerfield, Nicolas Ruggli · 2015 · Frontiers in Veterinary Science
Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines
Nobutaka Hanagata, Huijie Zhang, Chen, Chunyi Zhi, Tomohiko Yamazaki · 2013 · International Journal of Nanomedicine
Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice
Lisa Munakata, Yoshihiko Tanimoto, Akio Osa, Jie Meng, Yasunari Haseda, Yujiro Naito, Hirotomo Machiyama, Atsushi Kumanogoh, Daiki Omata, Kazuo Maruyama et al. · 2019 · Journal of Controlled Release
CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance
Guillem Montamat, Cathy Leonard, Aurélie Poli, Ludger Klimek, Markus W. Ollert · 2021 · Frontiers in Immunology
Nanoparticles Encapsulating Hepatitis B Virus Cytosine-Phosphate-Guanosine Induce Therapeutic Immunity against HBV Infection
Shujuan Lv, Jun Wang, Shuang Dou, Xianzhu Yang, Xiang Ni, Rui Sun, Zhigang Tian, Haiming Wei · 2013 · Hepatology
The immunogenicity of CpG-antigen conjugates
Hermann Wagner · 2009 · Advanced Drug Delivery Reviews
Treatment with granulocyte–macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock
Joerg C. Schefold, Jan-Philip Zeden, René Pschowski, Ben Hammoud, Christina Fotopoulou, Dietrich Hasper, Gerhard Fusch, Stephan von Haehling, Hans‐Dieter Volk, Christian Meisel et al. · 2009 · Scandinavian Journal of Infectious Diseases
Structure-Dependent Modulation of Alpha Interferon Production by Porcine Circovirus 2 Oligodeoxyribonucleotide and CpG DNAs in Porcine Peripheral Blood Mononuclear Cells
Frida Hasslung Wikström, Brian M. Meehan, Mikael Berg, Sirje Timmusk, Josefine Elving, Lisbeth Fuxler, Mattias Magnusson, Gordon Allan, Francis McNeilly, Caroline Fossum · 2007 · Journal of Virology
Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors
Edward Hammond, Nicole M. Haynes, Carleen M. Cullinane, Todd V. Brennan, Darryn Bampton, Paul Handley, Tomislav Karoli, Fleur Lanksheer, Liwen Lin, Yiping Yang et al. · 2018 · Journal for ImmunoTherapy of Cancer
TLR9-Mediated Recognition of DNA
Thomas R Müller, Svetlana Hamm, Stefan Bauer · 2007 · Handbook of experimental pharmacology
Toll-like receptor 9 agonists as cancer therapeutics
Udo Holtick, Max Ernst Scheulen, Michael S. von Bergwelt‐Baildon, Martin R. Weihrauch · 2011 · Expert Opinion on Investigational Drugs
Immunosuppression Routed Via the Kynurenine Pathway: A Biochemical and Pathophysiologic Approach
Álvaro González, Nerea Varo, Estíbaliz Alegre, A. Ayechu Díaz, Ignacio Melero · 2008 · Advances in clinical chemistry
Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703
Manuel Schmidt, Nicole Hagner, Alberto Jesús Marco, Sven A. König-Merediz, Matthias Schroff, Burghardt Wittig · 2015 · Nucleic Acid Therapeutics
Exploiting viral properties for the rational design of modern vaccines
Gunther Spohn, Martin F. Bachmann · 2008 · Expert Review of Vaccines
Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis
Adriano Boasso, Caroline M. Royle, Spyridon Doumazos, Veronica N. Aquino, Mara Biasin, Luca Piacentini, Barbara Tavano, Dietmar Fuchs, Francesco Mazzotta, Sergio Lo Caputo et al. · 2011 · Blood
Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity
Zahari Raykov, Svetlana P. Grekova, Barbara Leuchs, Marc Aprahamian, Jean Rommelaere · 2008 · International Journal of Cancer
Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators
Shireen Nigar, Takeshi Shimosato · 2019 · Frontiers in Nutrition
Synthetic oligonucleotides as modulators of inflammation
Dennis M. Klinman, Hidekazu Shirota, Debra Tross, Takashi Sato, Sven Klaschik · 2008 · Journal of Leukocyte Biology
Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer’s disease pathology in aged squirrel monkeys
Patel, Akash G, Nehete, Pramod N, Krivoshik, Sara R, Pei, Xuewei, Cho, Elizabeth L, Nehete, Bharti P, Ramani, Margish D, Shao, Yongzhao, Williams, Lawrence E, Wisniewski, Thomas et al. · 2021 · Brain
Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice
Alexander Krogmann, Enzo Lüsebrink, Martin Steinmetz, Tobias Asdonk, Catharina Lahrmann, Dieter Lütjohann, Georg Nickenig, Sebastian Zimmer · 2016 · PLoS ONE
Lipid Nanoparticle Acts as a Potential Adjuvant for Influenza Split Vaccine without Inducing Inflammatory Responses
Seiki Shirai, Atsushi Kawai, Meito Shibuya, Lisa Munakata, Daiki Omata, Ryo Suzuki, Yasuo Yoshioka · 2020 · Vaccines
Neuroinflammation in Prion Disease
Bei Li, Meiling Chen, Caihong Zhu · 2021 · International Journal of Molecular Sciences
Carrier molecules for use in veterinary vaccines
Volker Gerdts, George Mutwiri, James M. Richards, Sylvia van Drunen Littel‐van den Hurk, Andrew A. Potter · 2012 · Vaccine
Prions, Cytokines, and Chemokines: A Meeting in Lymphoid Organs
Adriano Aguzzi, Mathias F Heikenwälder · 2005 · Immunity
Immune homeostasis and regulation of the interferon pathway require myeloid-derived Regnase-3
Matthias von Gamm, Annalisa Schaub, Alisha N Jones, Christine Wolf, Gesine Behrens, Johannes Lichti, Katharina Essig, Anna Macht, Joachim Pircher, Andreas Ehrlich et al. · 2019 · The Journal of Experimental Medicine
Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Giacoma Galizzi, Marta Di Carlo · 2023 · Current Issues in Molecular Biology
Topical resiquimod promotes priming of CTL to parenteral antigens
Brent A. Chang, Jennifer L. Cross, Hossain M. Najar, Jan Peter Dutz · 2009 · Vaccine
Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity
Angela J. Henderson, Katie L. Propst, Ross M. Kedl, STEVEN W. DOW · 2011 · Vaccine
Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse
Angus Lee, M. Ghoreishi, W. K. Cheng, T.-Y. E. Chang, Y. Q. Zhang, Jan Peter Dutz · 2011 · Diabetologia
Production of antibodies with peptide-CpG-DNA-liposome complex without carriers
Dongbum Kim, Sanghoon Kwon, Jae Won Rhee, Kwang Dong Kim, Young‐Eun Kim, Cheung‐Seog Park, Myeong Jun Choi, Jun-Gyo Suh, Doo‐Sik Kim, Younghee Lee et al. · 2011 · BMC Immunology
The immunophysiological impact of bacterial CpG DNA on the gut
James L. Watson, Derek Mark McKay · 2005 · Clinica Chimica Acta
In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides
Hisaki Fujii, Jacqueline D. Trudeau, David T. Teachey, Jonathan D. Fish, Stephan A. Grupp, Kirk R. Schultz, Gregor S. D. Reid · 2006 · Blood
Recent developments in prion immunotherapy
Frank L. Heppner, Adriano Aguzzi · 2004 · Current Opinion in Immunology
CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity
Jing Jie, Yixin Zhang, Hongyue Zhou, Xiaoyu Zhai, Nannan Zhang, Hongyan Yuan, Weihua Ni, Guixiang Tai · 2018 · International Journal of Molecular Sciences
Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies
Nicolas Huot, Steven E. Bosinger, Mirko Paiardini, Roger Keith Reeves, Michaela C. Müller-Trutwin · 2018 · Frontiers in Immunology
REVIEW ARTICLE: The Role of Toll‐Like Receptor Ligands/Agonists in Protection Against Genital HSV‐2 Infection
Navkiran Gill, Elizabeth J. Davies, Ali A. Ashkar · 2007 · American Journal of Reproductive Immunology
Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization
Hui-Shan Li, Da-Chuan Piao, Tao Jiang, Jin‐Duck Bok, Chong‐Su Cho, Yoonseok Lee, Sang‐Kee Kang, Yun-Jaie Choi · 2015 · Vaccine
Stimulation of Toll-Like Receptor 9 by Chronic Intraventricular Unmethylated Cytosine-Guanine DNA Infusion Causes Neuroinflammation and Impaired Spatial Memory
Simone C. Tauber, Sandra Ebert, Jochen Hans Weishaupt, Arno Reich, Roland Nau, Joachim Gerber · 2009 · Journal of Neuropathology & Experimental Neurology
An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen
Daiko Wakita, Kenji Chamoto, Yue Zhang, Yoshinori Narita, Daisuke Noguchi, Hideaki Ohnishi, Takeshi Iguchi, Tomoaki Sakai, Hiroaki Ikeda, Takashi Nishimura · 2006 · International Immunology
Excessive CpG 1668 stimulation triggers IL‐10 production by cDC that inhibits IFN‐α responses by pDC
Zoe Waibler, Martina Anzaghe, Abdo Konur, Shizuo Akira, Werner Müller, Ulrich Kalinke · 2008 · European Journal of Immunology
Prospects of vaccines for medically important fungi
Marta Feldmesser · 2005 · Medical Mycology
Nuclease-resistant signaling nanostructures made entirely of DNA oligonucleotides
Congcong Li, Shasha Luo, Jue Wang, Zhifa Shen, Zai‐Sheng Wu · 2021 · Nanoscale
Intratumoral delivery of brachytherapy and immunotherapy by a thermally triggered polypeptide depot
Garrett Kelly, Joshua J. Milligan, Eric M. Mastria, Sarah Kim, Stephanie R. Zelenetz, Jarrett Dobbins, Leon Y. Cai, Xinghai Li, Smita K. Nair, Ashutosh Chilkoti · 2022 · Journal of Controlled Release
Ig-like Transcript 7, but Not Bone Marrow Stromal Cell Antigen 2 (Also Known as HM1.24, Tetherin, or CD317), Modulates Plasmacytoid Dendritic Cell Function in Primary Human Blood Leukocytes
Barbara Tavano, Rui Pedro Galão, David R. M. Graham, Stuart J. D. Neil, Veronica N. Aquino, Dietmar Fuchs, Adriano Boasso · 2013 · The Journal of Immunology
Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides
Defne Bayık, İhsan Gürsel, Dennis M. Klinman · 2016 · Pharmacological Research
HIV interferes with SOCS‐1 and ‐3 expression levels driving immune activation
Regina C. Miller, Erika Schlaepfer, Stefan Baenziger, Reto Crameri, Sabine Zeller, Rahel Byland, Annette Audigé, David Nadal, Roberto F. Speck · 2011 · European Journal of Immunology
Immunometabolic reprogramming, another cancer hallmark
Vijay Kumar, John H. Stewart · 2023 · Frontiers in Immunology
Liposomes as Protein Carriers in Immunology
Lee Leserman · 2004 · Journal of Liposome Research
TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns
Elaine Cristina Cardoso, Nátalli Zanete Pereira, Gabrielle Eimi Mitsunari, Luanda Mara da Silva Oliveira, Rosa Maria de Souza Aveiro Ruocco, Rossana Pulcineli Vieira Francisco, Marcelo Zugaib, Alberto José da Silva Duarte, Maria Notomi Sato · 2013 · PLoS ONE
Adjuvanted influenza vaccines
Orli Even‐Or, Sarit Samira, Ronald Ellis, Eli Kedar, Yechezkel Barenholz · 2013 · Expert Review of Vaccines
Low molecular weight chitosan nanoparticles for CpG oligodeoxynucleotides delivery: Impact of molecular weight, degree of deacetylation, and mannosylation on intracellular uptake and cytokine induction
Oksana Babii, Zhenggang Wang, Guangyu Liu, Elisa C. Martinez, Sylvia van Drunen Littel‐van den Hurk, Lingyun Chen · 2020 · International Journal of Biological Macromolecules
Multitasking by Multivalent Circular DNA Aptamers
Daniel A. Di Giusto, Sarah M. Knox, Yuching Lai, Gregory D. Tyrelle, May T. Aung, Garry C. King · 2006 · ChemBioChem
PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice
Srinivas Garlapati, Nelson F. Eng, Heather L. Wilson, Rachelle M. Buchanan, George Mutwiri, Lorne A. Babiuk, Volker Gerdts · 2010 · Vaccine
Dendritic Cell‐Based Immunotherapy of Malignant Melanoma: Success and Limitations
Andrea Tuettenberg, Edgar Schmitt, Jürgen Knop, Helmut Jonuleit · 2007 · JDDG Journal der Deutschen Dermatologischen Gesellschaft